Fabry disease in patients with hypertrophic cardiomyopathy: A practical approach to diagnosis

Jiwon Seo, Minji Kim, Geu Ru Hong, Dae Seong Kim, Jang Won Son, In Jeong Cho, ChiYoung Shim, Hyuk-Jae Chang, Jong Won Ha, Namsik Chung

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This study aimed to develop a new set of screening criteria that is easily applicable and highly sensitive for the detection of patients at high risk of Fabry disease (FD) among hypertrophic cardiomyopathy (HCM) patients. We prospectively studied 273 consecutive unrelated patients who were referred to HCM clinic for unknown left ventricular hypertrophy. Among the 273 patients, we selected 65 high-risk patients who fulfilled at least one of our newly proposed screening criteria. All 273 patients were assayed for plasma α-galactosidase A (α-GAL A) activity. The new screening criteria were: (1) atypical HCM, (2) history or presence of documented arrhythmia, (3) short PR interval defined as <120 ms on electrocardiogram, and (4) symptoms of autonomic dysfunction. From this screening study, three unrelated patients (4.6%; 2 females and 1 male) were newly diagnosed with FD using α-GAL A activity and mutation analysis of the GLA gene. Using the screening method based on the newly proposed criteria, the prevalence of FD in our HCM population was 4.6% if at least one criterion was met and 18.8% if ≥3 criteria were met. Therefore, our proposed criteria are easily applicable and highly sensitive for classifying patients at high risk of FD from HCM patients.

Original languageEnglish
Pages (from-to)775-780
Number of pages6
JournalJournal of human genetics
Volume61
Issue number9
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Fabry Disease
Hypertrophic Cardiomyopathy
Galactosidases
Left Ventricular Hypertrophy
Cardiac Arrhythmias
Electrocardiography
History
Mutation

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Seo, J., Kim, M., Hong, G. R., Kim, D. S., Son, J. W., Cho, I. J., ... Chung, N. (2016). Fabry disease in patients with hypertrophic cardiomyopathy: A practical approach to diagnosis. Journal of human genetics, 61(9), 775-780. https://doi.org/10.1038/jhg.2016.52
Seo, Jiwon ; Kim, Minji ; Hong, Geu Ru ; Kim, Dae Seong ; Son, Jang Won ; Cho, In Jeong ; Shim, ChiYoung ; Chang, Hyuk-Jae ; Ha, Jong Won ; Chung, Namsik. / Fabry disease in patients with hypertrophic cardiomyopathy : A practical approach to diagnosis. In: Journal of human genetics. 2016 ; Vol. 61, No. 9. pp. 775-780.
@article{ab5322312135402e9102201dbd952cad,
title = "Fabry disease in patients with hypertrophic cardiomyopathy: A practical approach to diagnosis",
abstract = "This study aimed to develop a new set of screening criteria that is easily applicable and highly sensitive for the detection of patients at high risk of Fabry disease (FD) among hypertrophic cardiomyopathy (HCM) patients. We prospectively studied 273 consecutive unrelated patients who were referred to HCM clinic for unknown left ventricular hypertrophy. Among the 273 patients, we selected 65 high-risk patients who fulfilled at least one of our newly proposed screening criteria. All 273 patients were assayed for plasma α-galactosidase A (α-GAL A) activity. The new screening criteria were: (1) atypical HCM, (2) history or presence of documented arrhythmia, (3) short PR interval defined as <120 ms on electrocardiogram, and (4) symptoms of autonomic dysfunction. From this screening study, three unrelated patients (4.6{\%}; 2 females and 1 male) were newly diagnosed with FD using α-GAL A activity and mutation analysis of the GLA gene. Using the screening method based on the newly proposed criteria, the prevalence of FD in our HCM population was 4.6{\%} if at least one criterion was met and 18.8{\%} if ≥3 criteria were met. Therefore, our proposed criteria are easily applicable and highly sensitive for classifying patients at high risk of FD from HCM patients.",
author = "Jiwon Seo and Minji Kim and Hong, {Geu Ru} and Kim, {Dae Seong} and Son, {Jang Won} and Cho, {In Jeong} and ChiYoung Shim and Hyuk-Jae Chang and Ha, {Jong Won} and Namsik Chung",
year = "2016",
month = "9",
day = "1",
doi = "10.1038/jhg.2016.52",
language = "English",
volume = "61",
pages = "775--780",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "9",

}

Fabry disease in patients with hypertrophic cardiomyopathy : A practical approach to diagnosis. / Seo, Jiwon; Kim, Minji; Hong, Geu Ru; Kim, Dae Seong; Son, Jang Won; Cho, In Jeong; Shim, ChiYoung; Chang, Hyuk-Jae; Ha, Jong Won; Chung, Namsik.

In: Journal of human genetics, Vol. 61, No. 9, 01.09.2016, p. 775-780.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fabry disease in patients with hypertrophic cardiomyopathy

T2 - A practical approach to diagnosis

AU - Seo, Jiwon

AU - Kim, Minji

AU - Hong, Geu Ru

AU - Kim, Dae Seong

AU - Son, Jang Won

AU - Cho, In Jeong

AU - Shim, ChiYoung

AU - Chang, Hyuk-Jae

AU - Ha, Jong Won

AU - Chung, Namsik

PY - 2016/9/1

Y1 - 2016/9/1

N2 - This study aimed to develop a new set of screening criteria that is easily applicable and highly sensitive for the detection of patients at high risk of Fabry disease (FD) among hypertrophic cardiomyopathy (HCM) patients. We prospectively studied 273 consecutive unrelated patients who were referred to HCM clinic for unknown left ventricular hypertrophy. Among the 273 patients, we selected 65 high-risk patients who fulfilled at least one of our newly proposed screening criteria. All 273 patients were assayed for plasma α-galactosidase A (α-GAL A) activity. The new screening criteria were: (1) atypical HCM, (2) history or presence of documented arrhythmia, (3) short PR interval defined as <120 ms on electrocardiogram, and (4) symptoms of autonomic dysfunction. From this screening study, three unrelated patients (4.6%; 2 females and 1 male) were newly diagnosed with FD using α-GAL A activity and mutation analysis of the GLA gene. Using the screening method based on the newly proposed criteria, the prevalence of FD in our HCM population was 4.6% if at least one criterion was met and 18.8% if ≥3 criteria were met. Therefore, our proposed criteria are easily applicable and highly sensitive for classifying patients at high risk of FD from HCM patients.

AB - This study aimed to develop a new set of screening criteria that is easily applicable and highly sensitive for the detection of patients at high risk of Fabry disease (FD) among hypertrophic cardiomyopathy (HCM) patients. We prospectively studied 273 consecutive unrelated patients who were referred to HCM clinic for unknown left ventricular hypertrophy. Among the 273 patients, we selected 65 high-risk patients who fulfilled at least one of our newly proposed screening criteria. All 273 patients were assayed for plasma α-galactosidase A (α-GAL A) activity. The new screening criteria were: (1) atypical HCM, (2) history or presence of documented arrhythmia, (3) short PR interval defined as <120 ms on electrocardiogram, and (4) symptoms of autonomic dysfunction. From this screening study, three unrelated patients (4.6%; 2 females and 1 male) were newly diagnosed with FD using α-GAL A activity and mutation analysis of the GLA gene. Using the screening method based on the newly proposed criteria, the prevalence of FD in our HCM population was 4.6% if at least one criterion was met and 18.8% if ≥3 criteria were met. Therefore, our proposed criteria are easily applicable and highly sensitive for classifying patients at high risk of FD from HCM patients.

UR - http://www.scopus.com/inward/record.url?scp=84988914978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988914978&partnerID=8YFLogxK

U2 - 10.1038/jhg.2016.52

DO - 10.1038/jhg.2016.52

M3 - Article

C2 - 27225851

AN - SCOPUS:84988914978

VL - 61

SP - 775

EP - 780

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 9

ER -